Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
暂无分享,去创建一个
B. Coiffier | O. Casasnovas | H. Tilly | N. Mounier | R. Herbrecht | B. Christian | E. Jourdan | K. Belhadj | A. Sonet | S. Bologna | C. Fermé